Skip to main content
Erschienen in: Endocrine 3/2012

01.06.2012 | Review

A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy

verfasst von: Xinli Zhang, Chen Chen

Erschienen in: Endocrine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Diabetes mellitus is one of the most common chronic diseases across the world. Cardiovascular complication is the major morbidity and mortality among the diabetic patients. Diabetic cardiomyopathy, a new entity independent of coronary artery disease or hypertension, has been increasingly recognized by clinicians and epidemiologists. Cardiac dysfunction is the major characteristic of diabetic cardiomyopathy. For a better understanding of diabetic cardiomyopathy and necessary treatment strategy, several pathological mechanisms such as impaired calcium handling and increased oxidative stress, have been proposed through clinical and experimental observations. In this review, we will discuss the development of cardiac dysfunction, the mechanisms underlying diabetic cardiomyopathy, diagnostic methods, and treatment options.
Literatur
3.
Zurück zum Zitat T.J. Regan, M.M. Lyons, S.S. Ahmed, G.E. Levinson, H.A. Oldewurtel, M.R. Ahmad, B. Haider, Evidence for cardiomyopathy in familial dabetes-mellitus. J. Clin. Invest. 60(4), 885–899 (1977). doi:10.1172/jci108843 CrossRef T.J. Regan, M.M. Lyons, S.S. Ahmed, G.E. Levinson, H.A. Oldewurtel, M.R. Ahmad, B. Haider, Evidence for cardiomyopathy in familial dabetes-mellitus. J. Clin. Invest. 60(4), 885–899 (1977). doi:10.​1172/​jci108843 CrossRef
4.
Zurück zum Zitat E. Astorri, P. Fiorina, A. Astorri, G.A. Contini, D. Albertini, G. Magnati, M. Lanfredini, Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin. Cardiol. 20(6), 536–540 (1997). doi:10.1002/clc.4960200606 PubMedCrossRef E. Astorri, P. Fiorina, A. Astorri, G.A. Contini, D. Albertini, G. Magnati, M. Lanfredini, Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin. Cardiol. 20(6), 536–540 (1997). doi:10.​1002/​clc.​4960200606 PubMedCrossRef
5.
Zurück zum Zitat M. Zabalgoitia, M.F. Ismaeil, L. Anderson, F.A. Maklady, Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am. J. Cardiol. 87(3), 320–323 (2001). doi:10.1016/s0002-9149(00)01366-7 PubMedCrossRef M. Zabalgoitia, M.F. Ismaeil, L. Anderson, F.A. Maklady, Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am. J. Cardiol. 87(3), 320–323 (2001). doi:10.​1016/​s0002-9149(00)01366-7 PubMedCrossRef
7.
Zurück zum Zitat W. Hsueh, E.D. Abel, J.L. Breslow, N. Maeda, R.C. Davis, E.A. Fisher, H. Dansky, D.A. McClain, R. McIndoe, M.K. Wassef, C. Rabadan-Diehl, I.J. Goldberg, Recipes for creating animal models of diabetic cardiovascular disease. Circ. Res. 100(10), 1415–1427 (2007). doi:10.1161/01.RES.0000266449.37396.1f PubMedCrossRef W. Hsueh, E.D. Abel, J.L. Breslow, N. Maeda, R.C. Davis, E.A. Fisher, H. Dansky, D.A. McClain, R. McIndoe, M.K. Wassef, C. Rabadan-Diehl, I.J. Goldberg, Recipes for creating animal models of diabetic cardiovascular disease. Circ. Res. 100(10), 1415–1427 (2007). doi:10.​1161/​01.​RES.​0000266449.​37396.​1f PubMedCrossRef
9.
Zurück zum Zitat C. Christoffersen, E. Bollano, M.L.S. Lindegaard, E.D. Bartels, J.P. Goetze, C.B. Andersen, L.B. Nielsen, Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144(8), 3483–3490 (2003). doi:10.1210/en.2003-0242 PubMedCrossRef C. Christoffersen, E. Bollano, M.L.S. Lindegaard, E.D. Bartels, J.P. Goetze, C.B. Andersen, L.B. Nielsen, Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144(8), 3483–3490 (2003). doi:10.​1210/​en.​2003-0242 PubMedCrossRef
10.
Zurück zum Zitat F. Dong, X. Zhang, X. Yang, L.B. Esberg, H. Yang, Z. Zhang, B. Culver, J. Ren, Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J. Endocrinol. 188(1), 25–36 (2006). doi:10.1677/joe.1.06241 PubMedCrossRef F. Dong, X. Zhang, X. Yang, L.B. Esberg, H. Yang, Z. Zhang, B. Culver, J. Ren, Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J. Endocrinol. 188(1), 25–36 (2006). doi:10.​1677/​joe.​1.​06241 PubMedCrossRef
11.
Zurück zum Zitat T.O. Stolen, M.A. Hoydal, O.J. Kemi, D. Catalucci, M. Ceci, E. Aasum, T. Larsen, N. Rolim, G. Condorelli, G.L. Smith, U. Wisloff, Interval training normalizes cardiomyocyte function, diastolic Ca(2+) control, and SR Ca(2+) release synchronicity in a mouse model of diabetic cardiomyopathy. Circ. Res. 105(6), U527–U547 (2009). doi:10.1161/circresaha.109.199810 CrossRef T.O. Stolen, M.A. Hoydal, O.J. Kemi, D. Catalucci, M. Ceci, E. Aasum, T. Larsen, N. Rolim, G. Condorelli, G.L. Smith, U. Wisloff, Interval training normalizes cardiomyocyte function, diastolic Ca(2+) control, and SR Ca(2+) release synchronicity in a mouse model of diabetic cardiomyopathy. Circ. Res. 105(6), U527–U547 (2009). doi:10.​1161/​circresaha.​109.​199810 CrossRef
15.
Zurück zum Zitat C.M. Yu, H. Lin, H. Yang, S.L. Kong, Q. Zhang, S.W.L. Lee, Progression of systolic abnormalities in patients with “isolated” diastolic heart failure and diastolic dysfunction. Circulation 105(10), 1195–1201 (2002). doi:10.1161/hc1002.105185 PubMedCrossRef C.M. Yu, H. Lin, H. Yang, S.L. Kong, Q. Zhang, S.W.L. Lee, Progression of systolic abnormalities in patients with “isolated” diastolic heart failure and diastolic dysfunction. Circulation 105(10), 1195–1201 (2002). doi:10.​1161/​hc1002.​105185 PubMedCrossRef
16.
Zurück zum Zitat P. Yue, T. Arai, M. Terashima, A.Y. Sheikh, F. Cao, D. Charo, G. Hoyt, R.C. Robbins, E.A. Ashley, J. Wu, P.C. Yang, P.S. Tsao, Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. Am. J. Physiol. Heart Circul. Physiol. 292(5), H2106–H2118 (2007). doi:10.1152/ajpheart.00856.2006 CrossRef P. Yue, T. Arai, M. Terashima, A.Y. Sheikh, F. Cao, D. Charo, G. Hoyt, R.C. Robbins, E.A. Ashley, J. Wu, P.C. Yang, P.S. Tsao, Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. Am. J. Physiol. Heart Circul. Physiol. 292(5), H2106–H2118 (2007). doi:10.​1152/​ajpheart.​00856.​2006 CrossRef
17.
Zurück zum Zitat T. Radovits, S. Korkmaz, S. Loganathan, E. Barnucz, T. Bomicke, R. Arif, M. Karck, G. Szabo, Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am. J. Physiol. Heart Circul. Physiol. 297(1), H125–H133 (2009). doi:10.1152/ajpheart.00165.2009 CrossRef T. Radovits, S. Korkmaz, S. Loganathan, E. Barnucz, T. Bomicke, R. Arif, M. Karck, G. Szabo, Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am. J. Physiol. Heart Circul. Physiol. 297(1), H125–H133 (2009). doi:10.​1152/​ajpheart.​00165.​2009 CrossRef
20.
Zurück zum Zitat R. Coleman, T. Hayek, S. Keidar, M. Aviram, A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E-0) mice. Acta Histochem. 108(6), 415–424 (2006). doi:10.1016/j.acthis.2006.07.002 PubMedCrossRef R. Coleman, T. Hayek, S. Keidar, M. Aviram, A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E-0) mice. Acta Histochem. 108(6), 415–424 (2006). doi:10.​1016/​j.​acthis.​2006.​07.​002 PubMedCrossRef
21.
Zurück zum Zitat J.F. James, T.E. Hewett, J. Robbins, Cardiac physiology in transgenic mice. Circ. Res. 82(4), 407–415 (1998)PubMed J.F. James, T.E. Hewett, J. Robbins, Cardiac physiology in transgenic mice. Circ. Res. 82(4), 407–415 (1998)PubMed
26.
Zurück zum Zitat G.D. Lopaschuk, A.G. Tahiliani, R. Vadlamudi, S. Katz, J.H. McNeill, Cardiac sarcoplasmic-reticulum function in insulin-treated diabetic rats. Am. J. Physiol. 245(6), H969–H976 (1983)PubMed G.D. Lopaschuk, A.G. Tahiliani, R. Vadlamudi, S. Katz, J.H. McNeill, Cardiac sarcoplasmic-reticulum function in insulin-treated diabetic rats. Am. J. Physiol. 245(6), H969–H976 (1983)PubMed
28.
Zurück zum Zitat K.M. Choi, Y. Zhong, B.D. Hoit, I.L. Grupp, H. Hahn, K.W. Dilly, S. Guatimosim, W.J. Lederer, M.A. Matlib, Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am. J. Physiol. Heart Circul. Physiol. 283(4), H1398–H1408 (2002). doi:10.1152/ajpheart.00313.2002 K.M. Choi, Y. Zhong, B.D. Hoit, I.L. Grupp, H. Hahn, K.W. Dilly, S. Guatimosim, W.J. Lederer, M.A. Matlib, Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am. J. Physiol. Heart Circul. Physiol. 283(4), H1398–H1408 (2002). doi:10.​1152/​ajpheart.​00313.​2002
31.
Zurück zum Zitat H. Kashihara, Z.Q. Shi, J.Z. Yu, J.H. McNeill, G.F. Tibbits, Effects of diabetes and hypertension on myocardial Na+–Ca2+exchange. Can. J. Physiol. Pharmacol. 78(1), 12–19 (2000). doi:10.1139/cjpp-78-1-12 PubMedCrossRef H. Kashihara, Z.Q. Shi, J.Z. Yu, J.H. McNeill, G.F. Tibbits, Effects of diabetes and hypertension on myocardial Na+–Ca2+exchange. Can. J. Physiol. Pharmacol. 78(1), 12–19 (2000). doi:10.​1139/​cjpp-78-1-12 PubMedCrossRef
32.
33.
Zurück zum Zitat C.E. Flarsheim, I.L. Grupp, M.A. Matlib, Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am. J. Physiol. Heart Circul. Physiol. 271(1), H192–H202 (1996) C.E. Flarsheim, I.L. Grupp, M.A. Matlib, Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am. J. Physiol. Heart Circul. Physiol. 271(1), H192–H202 (1996)
34.
Zurück zum Zitat P.J. Oliveira, R. Seica, P.M. Coxito, A.P. Rolo, C.M. Palmeira, M.S. Santos, A.J.M. Moreno, Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats. FEBS Lett. 554(3), 511–514 (2003). doi:10.1016/s0014-5793(03)01233-x PubMedCrossRef P.J. Oliveira, R. Seica, P.M. Coxito, A.P. Rolo, C.M. Palmeira, M.S. Santos, A.J.M. Moreno, Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats. FEBS Lett. 554(3), 511–514 (2003). doi:10.​1016/​s0014-5793(03)01233-x PubMedCrossRef
36.
Zurück zum Zitat D.C. Wallace, A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found. symp. 235, 247–263 (2001). discussion 263–246 PubMedCrossRef D.C. Wallace, A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found. symp. 235, 247–263 (2001). discussion 263–246 PubMedCrossRef
37.
Zurück zum Zitat A. Frustaci, J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, A. Maseri, B. Nadal-Ginard, P. Anversa, Myocardial cell death in human diabetes. Circ. Res. 87(12), 1123–1132 (2000)PubMed A. Frustaci, J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, A. Maseri, B. Nadal-Ginard, P. Anversa, Myocardial cell death in human diabetes. Circ. Res. 87(12), 1123–1132 (2000)PubMed
38.
Zurück zum Zitat L. Cai, J.X. Wang, Y. Li, X.H. Sun, L.P. Wang, Z.X. Zhou, Y.J. Kang, Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 54(6), 1829–1837 (2005). doi:10.2337/diabetes.54.6.1829 PubMedCrossRef L. Cai, J.X. Wang, Y. Li, X.H. Sun, L.P. Wang, Z.X. Zhou, Y.J. Kang, Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 54(6), 1829–1837 (2005). doi:10.​2337/​diabetes.​54.​6.​1829 PubMedCrossRef
39.
Zurück zum Zitat I.V. Turko, L. Li, K.S. Aulak, D.J. Stuehr, J.Y. Chang, F. Murad, Protein tyrosine nitration in the mitochondria from diabetic mouse heart—implications to dysfunctional mitochondria in diabetes. J. Biol. Chem. 278(36), 33972–33977 (2003). doi:10.1074/jbc.M303734200 PubMedCrossRef I.V. Turko, L. Li, K.S. Aulak, D.J. Stuehr, J.Y. Chang, F. Murad, Protein tyrosine nitration in the mitochondria from diabetic mouse heart—implications to dysfunctional mitochondria in diabetes. J. Biol. Chem. 278(36), 33972–33977 (2003). doi:10.​1074/​jbc.​M303734200 PubMedCrossRef
42.
Zurück zum Zitat S. Boudina, S. Sena, H. Theobald, X.M. Sheng, J.J. Wright, X.X. Hu, S. Aziz, J.I. Johnson, H. Bugger, V.G. Zaha, E.D. Abel, Mitochondrial energetics in the heart in obesity-related diabetes—direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56(10), 2457–2466 (2007). doi:10.2337/db07-0481 PubMedCrossRef S. Boudina, S. Sena, H. Theobald, X.M. Sheng, J.J. Wright, X.X. Hu, S. Aziz, J.I. Johnson, H. Bugger, V.G. Zaha, E.D. Abel, Mitochondrial energetics in the heart in obesity-related diabetes—direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56(10), 2457–2466 (2007). doi:10.​2337/​db07-0481 PubMedCrossRef
45.
Zurück zum Zitat M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, K.C. Sourris, A.L.Y. Tan, K. Fukami, V. Thallas-Bonke, P.P. Nawroth, M. Brownlee, A. Bierhaus, M.E. Cooper, J.M. Forbes, RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J. Am. Soc. Nephrol. 20(4), 742–752 (2009). doi:10.1681/asn.2008050514 PubMedCrossRef M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, K.C. Sourris, A.L.Y. Tan, K. Fukami, V. Thallas-Bonke, P.P. Nawroth, M. Brownlee, A. Bierhaus, M.E. Cooper, J.M. Forbes, RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J. Am. Soc. Nephrol. 20(4), 742–752 (2009). doi:10.​1681/​asn.​2008050514 PubMedCrossRef
46.
Zurück zum Zitat L.N. Li, G. Renier, Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metab. Clin. Exp. 55(11), 1516–1523 (2006). doi:10.1016/j.metabol.2006.06.022 PubMedCrossRef L.N. Li, G. Renier, Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metab. Clin. Exp. 55(11), 1516–1523 (2006). doi:10.​1016/​j.​metabol.​2006.​06.​022 PubMedCrossRef
47.
Zurück zum Zitat J.S. Kim, Y.G. Jin, J.J. Lemasters, Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am. J. Physiol. Heart Circul. Physiol. 290(5), H2024–H2034 (2006). doi:10.1152/ajpheart.00683.2005 CrossRef J.S. Kim, Y.G. Jin, J.J. Lemasters, Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am. J. Physiol. Heart Circul. Physiol. 290(5), H2024–H2034 (2006). doi:10.​1152/​ajpheart.​00683.​2005 CrossRef
48.
Zurück zum Zitat G.S. Bhamra, D.J. Hausenloy, S.M. Davidson, R.D. Carr, M. Paiva, A.M. Wynne, M.M. Mocanu, D.M. Yellon, Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res. Cardiol. 103(3), 274–284 (2008). doi:10.1007/s00395-007-0691-y PubMedCrossRef G.S. Bhamra, D.J. Hausenloy, S.M. Davidson, R.D. Carr, M. Paiva, A.M. Wynne, M.M. Mocanu, D.M. Yellon, Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res. Cardiol. 103(3), 274–284 (2008). doi:10.​1007/​s00395-007-0691-y PubMedCrossRef
52.
53.
Zurück zum Zitat B.N. Finck, D.P. Kelly, Peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J. Mol. Cell. Cardiol. 34(10), 1249–1257 (2002). doi:10.1006/jmcc.2002.2061 PubMedCrossRef B.N. Finck, D.P. Kelly, Peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J. Mol. Cell. Cardiol. 34(10), 1249–1257 (2002). doi:10.​1006/​jmcc.​2002.​2061 PubMedCrossRef
54.
Zurück zum Zitat T. Aoyama, J.M. Peters, N. Iritani, T. Nakajima, K. Furihata, T. Hashimoto, F.J. Gonzalez, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPAR alpha). J. Biol. Chem. 273(10), 5678–5684 (1998). doi:10.1074/jbc.273.10.5678 PubMedCrossRef T. Aoyama, J.M. Peters, N. Iritani, T. Nakajima, K. Furihata, T. Hashimoto, F.J. Gonzalez, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPAR alpha). J. Biol. Chem. 273(10), 5678–5684 (1998). doi:10.​1074/​jbc.​273.​10.​5678 PubMedCrossRef
55.
Zurück zum Zitat J.G. Duncan, J.L. Fong, D.M. Medeiros, B.N. Finck, D.P. Kelly, Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1 alpha gene regulatory pathway. Circulation 115(7), 909–917 (2007). doi:10.1161/circulationaha.106.662296 PubMedCrossRef J.G. Duncan, J.L. Fong, D.M. Medeiros, B.N. Finck, D.P. Kelly, Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1 alpha gene regulatory pathway. Circulation 115(7), 909–917 (2007). doi:10.​1161/​circulationaha.​106.​662296 PubMedCrossRef
56.
Zurück zum Zitat J. Eckel, H. Reinauer, Insulin action on glucose-transport in isolated cardiac myocytes-signaling pathways and diabetes-induced alterations. Biochem. Soc. Trans. 18(6), 1125–1127 (1990)PubMed J. Eckel, H. Reinauer, Insulin action on glucose-transport in isolated cardiac myocytes-signaling pathways and diabetes-induced alterations. Biochem. Soc. Trans. 18(6), 1125–1127 (1990)PubMed
59.
Zurück zum Zitat C. Martin, R. Schulz, H. Post, P. Gres, G. Heusch, Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia. Am. J. Physiol. Heart Circul. Physiol. 284(6), H2320–H2324 (2003). doi:10.1152/ajpheart.01122.2002 C. Martin, R. Schulz, H. Post, P. Gres, G. Heusch, Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia. Am. J. Physiol. Heart Circul. Physiol. 284(6), H2320–H2324 (2003). doi:10.​1152/​ajpheart.​01122.​2002
60.
Zurück zum Zitat J. Buchanan, P.K. Mazumder, P. Hu, G. Chakrabarti, M.W. Roberts, U.J. Yun, R.C. Cooksey, S.E. Litwin, E.D. Abel, Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146(12), 5341–5349 (2005). doi:10.1210/en.2005-0938 PubMedCrossRef J. Buchanan, P.K. Mazumder, P. Hu, G. Chakrabarti, M.W. Roberts, U.J. Yun, R.C. Cooksey, S.E. Litwin, E.D. Abel, Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146(12), 5341–5349 (2005). doi:10.​1210/​en.​2005-0938 PubMedCrossRef
61.
Zurück zum Zitat L.R. Peterson, P. Herrero, K.B. Schechtman, S.B. Racette, A.D. Waggoner, Z. Kisrieva-Ware, C. Dence, S. Klein, J. Marsala, T. Meyer, R.J. Gropler, Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109(18), 2191–2196 (2004). doi:10.1161/01.cir.0000127959.28627.f8 PubMedCrossRef L.R. Peterson, P. Herrero, K.B. Schechtman, S.B. Racette, A.D. Waggoner, Z. Kisrieva-Ware, C. Dence, S. Klein, J. Marsala, T. Meyer, R.J. Gropler, Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109(18), 2191–2196 (2004). doi:10.​1161/​01.​cir.​0000127959.​28627.​f8 PubMedCrossRef
63.
Zurück zum Zitat L.K. Russell, C.M. Mansfield, J.J. Lehman, A. Kovacs, M. Courtois, J.E. Saffitz, D.M. Medeiros, M.L. Valencik, J.A. McDonald, D.P. Kelly, Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res. 94(4), 525–533 (2004). doi:10.1161/01.res.0000117088.36577.eb PubMedCrossRef L.K. Russell, C.M. Mansfield, J.J. Lehman, A. Kovacs, M. Courtois, J.E. Saffitz, D.M. Medeiros, M.L. Valencik, J.A. McDonald, D.P. Kelly, Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res. 94(4), 525–533 (2004). doi:10.​1161/​01.​res.​0000117088.​36577.​eb PubMedCrossRef
65.
66.
Zurück zum Zitat H. Bugger, D. Chen, C. Riehle, J. Soto, H.A. Theobald, X.X. Hu, B. Ganesan, B.C. Weimer, E.D. Abel, Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic Akita mice. Diabetes 58(9), 1986–1997 (2009). doi:10.2337/db09-0259 PubMedCrossRef H. Bugger, D. Chen, C. Riehle, J. Soto, H.A. Theobald, X.X. Hu, B. Ganesan, B.C. Weimer, E.D. Abel, Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic Akita mice. Diabetes 58(9), 1986–1997 (2009). doi:10.​2337/​db09-0259 PubMedCrossRef
68.
Zurück zum Zitat A. Kanazawa, Y. Nishio, A. Kashiwagi, H. Inagaki, R. Kikkawa, K. Horiike, Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart. Am. J. Physiol. Endocrinol. Metab. 282(4), E778–E785 (2002). doi:10.1152/ajpendo.00255.2001 PubMed A. Kanazawa, Y. Nishio, A. Kashiwagi, H. Inagaki, R. Kikkawa, K. Horiike, Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart. Am. J. Physiol. Endocrinol. Metab. 282(4), E778–E785 (2002). doi:10.​1152/​ajpendo.​00255.​2001 PubMed
70.
Zurück zum Zitat M. Di Carli, D. Bianco-Batlles, M.E. Landa, A. Kazmers, H. Groehn, O. Muzik, G. Grunberger, Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100(8), 813–819 (1999)PubMed M. Di Carli, D. Bianco-Batlles, M.E. Landa, A. Kazmers, H. Groehn, O. Muzik, G. Grunberger, Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100(8), 813–819 (1999)PubMed
71.
Zurück zum Zitat J.K. Kahn, B. Zola, J.E. Juni, A.I. Vinik, Radionuclide assessment of left-ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J. Am. Coll. Cardiol. 7(6), 1303–1309 (1986)PubMedCrossRef J.K. Kahn, B. Zola, J.E. Juni, A.I. Vinik, Radionuclide assessment of left-ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J. Am. Coll. Cardiol. 7(6), 1303–1309 (1986)PubMedCrossRef
73.
Zurück zum Zitat K.E.J. Airaksinen, M.J. Koistinen, M.J. Ikaheimo, H.V. Huikuri, U. Korhonen, H. Pirttiaho, M.K. Linnaluoto, J.T. Takkunen, Augmentation of atrial contribution to left-ventricular filling in IDDM subjects as assessed by Doppler echocardiography. Diabetes Care 12(2), 159–161 (1989). doi:10.2337/diacare.12.2.159 PubMedCrossRef K.E.J. Airaksinen, M.J. Koistinen, M.J. Ikaheimo, H.V. Huikuri, U. Korhonen, H. Pirttiaho, M.K. Linnaluoto, J.T. Takkunen, Augmentation of atrial contribution to left-ventricular filling in IDDM subjects as assessed by Doppler echocardiography. Diabetes Care 12(2), 159–161 (1989). doi:10.​2337/​diacare.​12.​2.​159 PubMedCrossRef
74.
Zurück zum Zitat P.T. Monteagudo, V.A. Moises, O. Kohlmann, A.B. Ribeiro, V.C. Lima, M.T. Zanella, Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin. Cardiol. 23(5), 371–375 (2000)PubMedCrossRef P.T. Monteagudo, V.A. Moises, O. Kohlmann, A.B. Ribeiro, V.C. Lima, M.T. Zanella, Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin. Cardiol. 23(5), 371–375 (2000)PubMedCrossRef
75.
Zurück zum Zitat M. Uusitupa, J. Mustonen, M. Laakso, P. Vainio, E. Lansimies, S. Talwar, K. Pyorala, Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic-patients free of cardiovascular-disease. Diabetologia 31(11), 783–791 (1988)PubMedCrossRef M. Uusitupa, J. Mustonen, M. Laakso, P. Vainio, E. Lansimies, S. Talwar, K. Pyorala, Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic-patients free of cardiovascular-disease. Diabetologia 31(11), 783–791 (1988)PubMedCrossRef
76.
Zurück zum Zitat J.Y. Park, N. Takahara, A. Gabriele, E. Chou, K. Naruse, K. Suzuma, T. Yamauchi, S.W. Ha, M. Meier, C.J. Rhodes, G.L. King, Induction of endothelin-1 expression by glucose—an effect of protein kinase C activation. Diabetes 49(7), 1239–1248 (2000). doi:10.2337/diabetes.49.7.1239 PubMedCrossRef J.Y. Park, N. Takahara, A. Gabriele, E. Chou, K. Naruse, K. Suzuma, T. Yamauchi, S.W. Ha, M. Meier, C.J. Rhodes, G.L. King, Induction of endothelin-1 expression by glucose—an effect of protein kinase C activation. Diabetes 49(7), 1239–1248 (2000). doi:10.​2337/​diabetes.​49.​7.​1239 PubMedCrossRef
77.
Zurück zum Zitat E. Chou, I. Suzuma, K.J. Way, D. Opland, A.C. Clermont, K. Naruse, K. Suzuma, N.L. Bowling, C.J. Vlahos, L.P. Aiello, G.L. King, Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states—a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105(3), 373–379 (2002). doi:10.1161/hc0302.102143 PubMedCrossRef E. Chou, I. Suzuma, K.J. Way, D. Opland, A.C. Clermont, K. Naruse, K. Suzuma, N.L. Bowling, C.J. Vlahos, L.P. Aiello, G.L. King, Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states—a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105(3), 373–379 (2002). doi:10.​1161/​hc0302.​102143 PubMedCrossRef
78.
Zurück zum Zitat K. Shinohara, T. Shinohara, N. Mochizuki, Y. Mochizukik, H. Sawa, T. Kohya, M. Fujita, Y. Fujioka, A. Kitabatake, K. Nagashima, Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels 11(3), 113–122 (1996). doi:10.1007/bf01745169 PubMedCrossRef K. Shinohara, T. Shinohara, N. Mochizuki, Y. Mochizukik, H. Sawa, T. Kohya, M. Fujita, Y. Fujioka, A. Kitabatake, K. Nagashima, Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels 11(3), 113–122 (1996). doi:10.​1007/​bf01745169 PubMedCrossRef
79.
Zurück zum Zitat Y.S. Yoon, S. Uchida, O. Masuo, M. Cejna, J.S. Park, H.C. Gwon, R. Kirchmair, F. Bahlman, D. Walter, C. Curry, A. Hanley, J.M. Isner, D.W. Losordo, Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy—restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111(16), 2073–2085 (2005). doi:10.1161/01.cir.0000162472.52990.36 PubMedCrossRef Y.S. Yoon, S. Uchida, O. Masuo, M. Cejna, J.S. Park, H.C. Gwon, R. Kirchmair, F. Bahlman, D. Walter, C. Curry, A. Hanley, J.M. Isner, D.W. Losordo, Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy—restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111(16), 2073–2085 (2005). doi:10.​1161/​01.​cir.​0000162472.​52990.​36 PubMedCrossRef
80.
Zurück zum Zitat S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C.N. Mowa, S. Maeda, Y. Hattori, T. Miyauchi, Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Am. J. Physiol. Endocrinol. Metab. 292(4), E1030–E1040 (2007). doi:10.1152/ajpendo.00517.2006 PubMedCrossRef S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C.N. Mowa, S. Maeda, Y. Hattori, T. Miyauchi, Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Am. J. Physiol. Endocrinol. Metab. 292(4), E1030–E1040 (2007). doi:10.​1152/​ajpendo.​00517.​2006 PubMedCrossRef
81.
Zurück zum Zitat Y. Hattori, H. Kawasaki, K. Abe, M. Kanno, Superoxide-dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261(4), H1086–H1094 (1991)PubMed Y. Hattori, H. Kawasaki, K. Abe, M. Kanno, Superoxide-dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261(4), H1086–H1094 (1991)PubMed
82.
Zurück zum Zitat R. Bucala, K.J. Tracey, A. Cerami, Advanced glycosylation products quench nitric-oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87(2), 432–438 (1991). doi:10.1172/jci115014 PubMedCrossRef R. Bucala, K.J. Tracey, A. Cerami, Advanced glycosylation products quench nitric-oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87(2), 432–438 (1991). doi:10.​1172/​jci115014 PubMedCrossRef
83.
Zurück zum Zitat C. Andersson, G.H. Gislason, P. Weeke, S. Hoffmann, P.R. Hansen, C. Torp-Pedersen, P. Sogaard, Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc. Diabetol. 9, 3 (2010). doi:310.1186/1475-2840-9-3 PubMedCrossRef C. Andersson, G.H. Gislason, P. Weeke, S. Hoffmann, P.R. Hansen, C. Torp-Pedersen, P. Sogaard, Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc. Diabetol. 9, 3 (2010). doi:310.​1186/​1475-2840-9-3 PubMedCrossRef
86.
Zurück zum Zitat F. Fiordaliso, B.S. Li, R. Latini, E.H. Sonnenblick, P. Anversa, A. Leri, J. Kajstura, Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab. Invest. 80(4), 513–527 (2000)PubMed F. Fiordaliso, B.S. Li, R. Latini, E.H. Sonnenblick, P. Anversa, A. Leri, J. Kajstura, Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab. Invest. 80(4), 513–527 (2000)PubMed
89.
Zurück zum Zitat S. Gunasegaram, R.S. Haworth, D.J. Hearse, M. Avkiran, Regulation of sarcolemmal Na+/H+ exchanger activity by angiotensin II in adult rat ventricular myocytes opposing actions via AT(1) versus AT(2) receptors. Circ. Res. 85(10), 919–930 (1999)PubMed S. Gunasegaram, R.S. Haworth, D.J. Hearse, M. Avkiran, Regulation of sarcolemmal Na+/H+ exchanger activity by angiotensin II in adult rat ventricular myocytes opposing actions via AT(1) versus AT(2) receptors. Circ. Res. 85(10), 919–930 (1999)PubMed
90.
Zurück zum Zitat N. Yaras, A. Bilginoglu, G. Vassort, B. Turan, Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade. Am. J. Physiol. Heart Circul. Physiol. 292(2), H912–H920 (2007). doi:10.1152/ajpheart.00824.2006 CrossRef N. Yaras, A. Bilginoglu, G. Vassort, B. Turan, Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade. Am. J. Physiol. Heart Circul. Physiol. 292(2), H912–H920 (2007). doi:10.​1152/​ajpheart.​00824.​2006 CrossRef
91.
Zurück zum Zitat X.L. Liu, H. Suzuki, R. Sethi, P.S. Tappia, N. Takeda, N.S. Dhalla, Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes, in Diabetes Mellitus and Its Complications: Molecular Mechanisms, Epidemiology, and Clinical Medicine, vol. 1084, ed. by E. Adeghate, H. Saadi, A. Adem, E. Obineche. Annals of the New York Academy of Sciences (Blackwell Publishing, Oxford, 2006), pp. 141–154 X.L. Liu, H. Suzuki, R. Sethi, P.S. Tappia, N. Takeda, N.S. Dhalla, Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes, in Diabetes Mellitus and Its Complications: Molecular Mechanisms, Epidemiology, and Clinical Medicine, vol. 1084, ed. by E. Adeghate, H. Saadi, A. Adem, E. Obineche. Annals of the New York Academy of Sciences (Blackwell Publishing, Oxford, 2006), pp. 141–154
92.
Zurück zum Zitat J. Kajstura, F. Fiordaliso, A.M. Andreoli, B.S. Li, S. Chimenti, M.S. Medow, F. Limana, B. Nadal-Ginard, A. Leri, P. Anversa, IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50(6), 1414–1424 (2001). doi:10.2337/diabetes.50.6.1414 PubMedCrossRef J. Kajstura, F. Fiordaliso, A.M. Andreoli, B.S. Li, S. Chimenti, M.S. Medow, F. Limana, B. Nadal-Ginard, A. Leri, P. Anversa, IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50(6), 1414–1424 (2001). doi:10.​2337/​diabetes.​50.​6.​1414 PubMedCrossRef
93.
Zurück zum Zitat A. Leri, Y. Liu, X.W. Wang, J. Kajstura, A. Malhotra, L.G. Meggs, P. Anversa, Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ. Res. 84(7), 752–762 (1999)PubMed A. Leri, Y. Liu, X.W. Wang, J. Kajstura, A. Malhotra, L.G. Meggs, P. Anversa, Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ. Res. 84(7), 752–762 (1999)PubMed
94.
Zurück zum Zitat Z. Yu, G.F. Tibbits, J.H. McNeill, Cellular functions of diabetic cardiomyocytes—contractility, rapid-cooling contracture, and ryanodine binding. Am. J. Physiol. 266(5), H2082–H2089 (1994)PubMed Z. Yu, G.F. Tibbits, J.H. McNeill, Cellular functions of diabetic cardiomyocytes—contractility, rapid-cooling contracture, and ryanodine binding. Am. J. Physiol. 266(5), H2082–H2089 (1994)PubMed
96.
Zurück zum Zitat R.A. Bouchard, D. Bose, Influence of experimental diabetes on sarcoplasmic-reticulum function in rat ventricular muscle. Am. J. Physiol. 260(2), H341–H354 (1991)PubMed R.A. Bouchard, D. Bose, Influence of experimental diabetes on sarcoplasmic-reticulum function in rat ventricular muscle. Am. J. Physiol. 260(2), H341–H354 (1991)PubMed
97.
Zurück zum Zitat S. Nobe, M. Aomine, M. Arita, S. Ito, R. Takaki, Chronic diabetes mellitus prolong action-potential duration of rat ventricular muscles—circumstantial evidence for impaired Ca2+ channel. Cardiovasc. Res. 24(5), 381–389 (1990). doi:10.1093/cvr/24.5.381 PubMedCrossRef S. Nobe, M. Aomine, M. Arita, S. Ito, R. Takaki, Chronic diabetes mellitus prolong action-potential duration of rat ventricular muscles—circumstantial evidence for impaired Ca2+ channel. Cardiovasc. Res. 24(5), 381–389 (1990). doi:10.​1093/​cvr/​24.​5.​381 PubMedCrossRef
98.
Zurück zum Zitat D.Y. Qin, B.Y. Huang, L.L. Deng, H. El-Adawi, K. Ganguly, J.R. Sowers, N. El-Sherif, Downregulation of K+channel genes expression in type I diabetic cardiomyopathy. Biochem. Biophys. Res. Commun. 283(3), 549–553 (2001). doi:10.1006/bbrc.2001.4825 PubMedCrossRef D.Y. Qin, B.Y. Huang, L.L. Deng, H. El-Adawi, K. Ganguly, J.R. Sowers, N. El-Sherif, Downregulation of K+channel genes expression in type I diabetic cardiomyopathy. Biochem. Biophys. Res. Commun. 283(3), 549–553 (2001). doi:10.​1006/​bbrc.​2001.​4825 PubMedCrossRef
99.
Zurück zum Zitat S. Shigematsu, T. Maruyama, T. Kiyosue, M. Arita, Rate-dependent prolongation of action-potential duration in single ventricular myocytes obtained from hearts of rats with streptozotocin-induced chronic diabetes sustained for 30–32 weeks. Heart Vessels 9(6), 300–306 (1994). doi:10.1007/bf01745095 PubMedCrossRef S. Shigematsu, T. Maruyama, T. Kiyosue, M. Arita, Rate-dependent prolongation of action-potential duration in single ventricular myocytes obtained from hearts of rats with streptozotocin-induced chronic diabetes sustained for 30–32 weeks. Heart Vessels 9(6), 300–306 (1994). doi:10.​1007/​bf01745095 PubMedCrossRef
108.
Zurück zum Zitat J.N. Bella, R.B. Devereux, M.J. Roman, V. Palmieri, J.E. Liu, M. Paranicas, T.K. Welty, E.T. Lee, R.R. Fabsitz, B.V. Howard, Strong Heart Study Investigators, Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am. J. Cardiol. 87(11), 1260–1265 (2001). doi:10.1016/s0002-9149(01)01516-8 PubMedCrossRef J.N. Bella, R.B. Devereux, M.J. Roman, V. Palmieri, J.E. Liu, M. Paranicas, T.K. Welty, E.T. Lee, R.R. Fabsitz, B.V. Howard, Strong Heart Study Investigators, Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am. J. Cardiol. 87(11), 1260–1265 (2001). doi:10.​1016/​s0002-9149(01)01516-8 PubMedCrossRef
109.
Zurück zum Zitat A. Ilercil, R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O’Grady, T.K. Welty, D.C. Robbins, R.R. Fabsitz, B.V. Howard, E.T. Lee, Relationship of impaired glucose tolerance to left ventricular structure and function: the strong heart study. Am. Heart J. 141(6), 992–998 (2001). doi:10.1067/mhj.2001.115302 PubMedCrossRef A. Ilercil, R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O’Grady, T.K. Welty, D.C. Robbins, R.R. Fabsitz, B.V. Howard, E.T. Lee, Relationship of impaired glucose tolerance to left ventricular structure and function: the strong heart study. Am. Heart J. 141(6), 992–998 (2001). doi:10.​1067/​mhj.​2001.​115302 PubMedCrossRef
111.
Zurück zum Zitat Y.H. Chen, Y. Huang, X.Y. Li, M. Xu, Y.F. Bi, Y. Zhang, W.Q. Gu, G. Ning, Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine 36(2), 262–267 (2009). doi:10.1007/s12020-009-9221-z PubMedCrossRef Y.H. Chen, Y. Huang, X.Y. Li, M. Xu, Y.F. Bi, Y. Zhang, W.Q. Gu, G. Ning, Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine 36(2), 262–267 (2009). doi:10.​1007/​s12020-009-9221-z PubMedCrossRef
113.
Zurück zum Zitat C.M. Schannwell, M. Schneppenheim, S. Perings, G. Plehn, B.E. Strauer, Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98(1–2), 33–39 (2002). doi:10.1159/000064682 PubMedCrossRef C.M. Schannwell, M. Schneppenheim, S. Perings, G. Plehn, B.E. Strauer, Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98(1–2), 33–39 (2002). doi:10.​1159/​000064682 PubMedCrossRef
114.
Zurück zum Zitat S. Carugo, C. Giannattasio, I. Calchera, F. Paleari, M.G. Gorgoglione, A. Grappiolo, P. Gamba, G. Rovaris, M. Failla, G. Mancia, Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J. Hypertens. 19(9), 1675–1680 (2001). doi:10.1097/00004872-200109000-00021 PubMedCrossRef S. Carugo, C. Giannattasio, I. Calchera, F. Paleari, M.G. Gorgoglione, A. Grappiolo, P. Gamba, G. Rovaris, M. Failla, G. Mancia, Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J. Hypertens. 19(9), 1675–1680 (2001). doi:10.​1097/​00004872-200109000-00021 PubMedCrossRef
115.
Zurück zum Zitat T. Beljic, M. Miric, Improved metabolic control does not reverse left-ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients. Acta Diabetol. 31(3), 147–150 (1994)PubMedCrossRef T. Beljic, M. Miric, Improved metabolic control does not reverse left-ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients. Acta Diabetol. 31(3), 147–150 (1994)PubMedCrossRef
116.
Zurück zum Zitat A. Nicolino, G. Longobardi, G. Furgi, M. Rossi, N. Zoccolillo, N. Ferrara, F. Rengo, Left-ventricular diastolic filling in diabetes mellitus with and without hypertension. Am. J. Hypertens. 8(4), 382–389 (1995). doi:10.1016/0895-7061(95)00022-h PubMedCrossRef A. Nicolino, G. Longobardi, G. Furgi, M. Rossi, N. Zoccolillo, N. Ferrara, F. Rengo, Left-ventricular diastolic filling in diabetes mellitus with and without hypertension. Am. J. Hypertens. 8(4), 382–389 (1995). doi:10.​1016/​0895-7061(95)00022-h PubMedCrossRef
117.
Zurück zum Zitat P. Poirier, P. Bogaty, C. Garneau, L. Marois, J.G. Dumesnil, Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes—importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24(1), 5–10 (2001). doi:10.2337/diacare.24.1.5 PubMedCrossRef P. Poirier, P. Bogaty, C. Garneau, L. Marois, J.G. Dumesnil, Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes—importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24(1), 5–10 (2001). doi:10.​2337/​diacare.​24.​1.​5 PubMedCrossRef
120.
Zurück zum Zitat T.R. Kimball, S.R. Daniels, P.R. Khoury, R.A. Magnotti, A.M. Turner, L.M. Dolan, Cardiovascular status in young patients with insulin-dependent diabetes mellitus. Circulation 90(1), 357–361 (1994)PubMed T.R. Kimball, S.R. Daniels, P.R. Khoury, R.A. Magnotti, A.M. Turner, L.M. Dolan, Cardiovascular status in young patients with insulin-dependent diabetes mellitus. Circulation 90(1), 357–361 (1994)PubMed
121.
Zurück zum Zitat R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O’Grady, E.T. Lee, T.K. Welty, R.R. Fabsitz, D. Robbins, E.R. Rhoades, B.V. Howard, Impact of diabetes on cardiac structure and function—the strong heart study. Circulation 101(19), 2271–2276 (2000)PubMed R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O’Grady, E.T. Lee, T.K. Welty, R.R. Fabsitz, D. Robbins, E.R. Rhoades, B.V. Howard, Impact of diabetes on cardiac structure and function—the strong heart study. Circulation 101(19), 2271–2276 (2000)PubMed
122.
Zurück zum Zitat M. Eren, S. Gorgulu, N. Uslu, S. Celik, B. Dagdeviren, T. Tezel, Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 90(1), 37–43 (2004). doi:10.1136/heart.90.1.37 PubMedCrossRef M. Eren, S. Gorgulu, N. Uslu, S. Celik, B. Dagdeviren, T. Tezel, Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 90(1), 37–43 (2004). doi:10.​1136/​heart.​90.​1.​37 PubMedCrossRef
124.
126.
Zurück zum Zitat P. Sogaard, H. Egeblad, A.K. Pedersen, W.Y. Kim, B.O. Kristensen, P.S. Hansen, P.T. Mortensen, Sequential versus simultaneous biventricular resynchronization for severe heart failure—evaluation by tissue Doppler imaging. Circulation 106(16), 2078–2084 (2002). doi:10.1161/01.cir.0000034512.90874.8e PubMedCrossRef P. Sogaard, H. Egeblad, A.K. Pedersen, W.Y. Kim, B.O. Kristensen, P.S. Hansen, P.T. Mortensen, Sequential versus simultaneous biventricular resynchronization for severe heart failure—evaluation by tissue Doppler imaging. Circulation 106(16), 2078–2084 (2002). doi:10.​1161/​01.​cir.​0000034512.​90874.​8e PubMedCrossRef
127.
Zurück zum Zitat J. Ren, W.K. Samson, J.R. Sowers, Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell. Cardiol. 31(11), 2049–2061 (1999). doi:10.1006/jmcc.1999.1036 PubMedCrossRef J. Ren, W.K. Samson, J.R. Sowers, Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell. Cardiol. 31(11), 2049–2061 (1999). doi:10.​1006/​jmcc.​1999.​1036 PubMedCrossRef
128.
Zurück zum Zitat F.L. Norby, L.E. Wold, J.H. Duan, K.K. Hintz, J. Ren, IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 283(4), E658–E666 (2002). doi:10.1152/ajpendo.00003.2002 PubMed F.L. Norby, L.E. Wold, J.H. Duan, K.K. Hintz, J. Ren, IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 283(4), E658–E666 (2002). doi:10.​1152/​ajpendo.​00003.​2002 PubMed
130.
Zurück zum Zitat A.I.M. Al-Shafei, R.G. Wise, G.A. Gresham, G. Bronns, T.A. Carpenter, L.D. Hall, C.L.H. Huang, Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J. Physiol. London 538(2), 541–553 (2002). doi:10.1013/jphysiol.2001.012856 PubMedCrossRef A.I.M. Al-Shafei, R.G. Wise, G.A. Gresham, G. Bronns, T.A. Carpenter, L.D. Hall, C.L.H. Huang, Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J. Physiol. London 538(2), 541–553 (2002). doi:10.​1013/​jphysiol.​2001.​012856 PubMedCrossRef
131.
Zurück zum Zitat T. Sugawara, S. Fujii, T.A. Zaman, D. Goto, T. Kaneko, T. Furumoto, H. Togashi, M. Yoshioka, T. Koyama, A. Kitabatake, Coronary capillary remodeling in non-insulin-dependent diabetic rats: amelioration by inhibition of angiotensin converting enzyme and its potential clinical implications. Hypertens. Res. 24(1), 75–81 (2001). doi:10.1291/hypres.24.75 PubMedCrossRef T. Sugawara, S. Fujii, T.A. Zaman, D. Goto, T. Kaneko, T. Furumoto, H. Togashi, M. Yoshioka, T. Koyama, A. Kitabatake, Coronary capillary remodeling in non-insulin-dependent diabetic rats: amelioration by inhibition of angiotensin converting enzyme and its potential clinical implications. Hypertens. Res. 24(1), 75–81 (2001). doi:10.​1291/​hypres.​24.​75 PubMedCrossRef
132.
Zurück zum Zitat G. Miric, C. Dallemagne, Z. Endre, S. Margolin, S.M. Taylor, L. Brown, Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br. J. Pharmacol. 133(5), 687–694 (2001). doi:10.1038/sj.bjp.0704131 PubMedCrossRef G. Miric, C. Dallemagne, Z. Endre, S. Margolin, S.M. Taylor, L. Brown, Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br. J. Pharmacol. 133(5), 687–694 (2001). doi:10.​1038/​sj.​bjp.​0704131 PubMedCrossRef
133.
Zurück zum Zitat D. Grimm, H.C. Jabusch, P. Kossmehl, M. Huber, S. Fredersdorf, D.P. Griese, B.K. Kramer, E.P. Kromer, Experimental diabetes and left ventricular hypertrophy—effects of beta-receptor blockade. Cardiovasc. Pathol. 11(4), 229–237 (2002). doi:10.1016/s1054-8807(01)00116-8 PubMedCrossRef D. Grimm, H.C. Jabusch, P. Kossmehl, M. Huber, S. Fredersdorf, D.P. Griese, B.K. Kramer, E.P. Kromer, Experimental diabetes and left ventricular hypertrophy—effects of beta-receptor blockade. Cardiovasc. Pathol. 11(4), 229–237 (2002). doi:10.​1016/​s1054-8807(01)00116-8 PubMedCrossRef
134.
Zurück zum Zitat A. Bril, M. Slivjak, M.J. Dimartino, G.Z. Feuerstein, P. Linee, R.H. Poyser, R.R. Ruffolo, E.F. Smith, Cardioprotective effects of carvedilol, a novel beta-adrenoceptor antagonist with vasodilating properties, in anesthetized minipigs—comparison with propranolol. Cardiovasc. Res. 26(5), 518–525 (1992). doi:10.1093/cvr/26.5.518 PubMedCrossRef A. Bril, M. Slivjak, M.J. Dimartino, G.Z. Feuerstein, P. Linee, R.H. Poyser, R.R. Ruffolo, E.F. Smith, Cardioprotective effects of carvedilol, a novel beta-adrenoceptor antagonist with vasodilating properties, in anesthetized minipigs—comparison with propranolol. Cardiovasc. Res. 26(5), 518–525 (1992). doi:10.​1093/​cvr/​26.​5.​518 PubMedCrossRef
135.
Zurück zum Zitat M. Packer, A.J.S. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, D.L. DeMets, Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. 344(22), 1651–1658 (2001). doi:10.1056/nejm200105313442201 PubMedCrossRef M. Packer, A.J.S. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, D.L. DeMets, Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. 344(22), 1651–1658 (2001). doi:10.​1056/​nejm200105313442​201 PubMedCrossRef
Metadaten
Titel
A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy
verfasst von
Xinli Zhang
Chen Chen
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9623-1

Weitere Artikel der Ausgabe 3/2012

Endocrine 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.